Trials / Unknown
UnknownNCT05780840
Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
What is the visible light protective effect of dihydroxyacetone in individuals with erythropoietic protoporphyria? This will be tested in this randomized blinded placebo controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dihydroxyacetone | Application of 10% dihydroxyacetone (2 mg per square cm skin) |
| OTHER | Placebo | Application of lotion to the skin (2 mg per square cm skin) |
Timeline
- Start date
- 2023-02-23
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2023-03-23
- Last updated
- 2023-03-23
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05780840. Inclusion in this directory is not an endorsement.